Literature DB >> 18765931

1,25-Dihydroxy vitamin D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60-activated matrix vesicle matrix metalloproteinases.

B D Boyan1, Z Schwartz.   

Abstract

As growth plate chondrocytes mature and hypertrophy, they reorganize their proteoglycan-rich type II collagen extracellular matrix (ECM), involving 1,25(OH)(2)D(3)-dependent regulation of matrix metalloproteinases (MMPs). Stromelysin-1 (MMP-3) and 72-kD gelatinase (MMP-2) are found in extracellular matrix vesicles (MVs) and release and activate ECM-bound latent TGF-beta1 and TGF-beta2, respectively. 1,25(OH)(2)D(3) regulates incorporation of MMP-2 and MMP-3 into MVs and release of these enzymes in the ECM. Plasma membranes (PMs) and MVs contain the 1alpha,25(OH)(2)D(3) membrane receptor ERp60 (protein disulfide isomerase A3), phospholipase A(2) (PLA(2)), PLA(2)-activating protein, the nuclear vitamin D receptor and caveolin-1. 1,25(OH)(2)D(3) secreted by chondrocytes binds MV ERp60, activating PLA(2). Resulting lysophospholipids destabilize MV membranes, releasing active MMPs. We examined 1,25(OH)(2)D(3)-dependent activation of latent TGF-beta1 stored in cartilage ECM. Interestingly, TGF-beta1 regulates 1,25(OH)(2)D(3) production. 1alpha,25(OH)(2)D(3) activates PM protein kinase C (PKC)-alpha via ERp60-dependent PLA(2)-signaling, lysophospholipid production and phospholipase C-gamma. It also regulates distribution of phospholipids and PKC isoforms between MVs and PMs, enriching MVs in PKC-zeta. Direct activation of MV MMP-3 requires ERp60 based on blocking antibodies and PKC based on inhibitor studies. However, treatment of MVs with 1,25(OH)(2)D(3) decreases MV PKC-zeta activity, suggesting more complex feedback mechanisms, potentially involving MV lipid signaling. Our observations indicate that one role of MVs is to provide MMPs at sites distant from the cells. Chondrocytes secrete 1,25(OH)(2)D(3), which acts directly on MV-membranes via ERp60, releasing MMPs. MMP-specific ECM components are hydrolyzed, resulting in release and activation of growth factors that can act back on the cells. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18765931      PMCID: PMC2824185          DOI: 10.1159/000152916

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  24 in total

1.  Matrix vesicles are enriched in metalloproteinases that degrade proteoglycans.

Authors:  D D Dean; Z Schwartz; O E Muniz; R Gomez; L D Swain; D S Howell; B D Boyan
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

2.  Nongenomic regulation of protein kinase C isoforms by the vitamin D metabolites 1 alpha,25-(OH)2D3 and 24R,25-(OH)2D3.

Authors:  V L Sylvia; Z Schwartz; E B Ellis; S H Helm; R Gomez; D D Dean; B D Boyan
Journal:  J Cell Physiol       Date:  1996-06       Impact factor: 6.384

3.  Collagenase and gelatinase production by calcifying growth plate chondrocytes.

Authors:  R A Brown; M Kayser; B McLaughlin; J B Weiss
Journal:  Exp Cell Res       Date:  1993-09       Impact factor: 3.905

4.  Chondrocyte cultures express matrix metalloproteinase mRNA and immunoreactive protein; stromelysin-1 and 72 kDa gelatinase are localized in extracellular matrix vesicles.

Authors:  J P Schmitz; D D Dean; Z Schwartz; D L Cochran; G M Grant; R J Klebe; H Nakaya; B D Boyan
Journal:  J Cell Biochem       Date:  1996-06-01       Impact factor: 4.429

5.  Vitamin D regulation of metalloproteinase activity in matrix vesicles.

Authors:  D D Dean; Z Schwartz; J Schmitz; O E Muniz; Y Lu; F Calderon; D S Howell; B D Boyan
Journal:  Connect Tissue Res       Date:  1996       Impact factor: 3.417

6.  Latent transforming growth factor-beta is produced by chondrocytes and activated by extracellular matrix vesicles upon exposure to 1,25-(OH)2D3.

Authors:  B D Boyan; Z Schwartz; S Park-Snyder; D D Dean; F Yang; D Twardzik; L F Bonewald
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

7.  Vitamin D3 regulation of stromelysin-1 (MMP-3) in chondrocyte cultures is mediated by protein kinase C.

Authors:  J P Schmitz; Z Schwartz; V L Sylvia; D D Dean; F Calderon; B D Boyan
Journal:  J Cell Physiol       Date:  1996-09       Impact factor: 6.384

8.  Lysophospholipid regulates release and activation of latent TGF-beta1 from chondrocyte extracellular matrix.

Authors:  I Gay; Z Schwartz; V L Sylvia; B D Boyan
Journal:  Biochim Biophys Acta       Date:  2004-08-30

9.  Vitamin D metabolites regulate matrix vesicle metalloproteinase content in a cell maturation-dependent manner.

Authors:  D D Dean; B D Boyan; O E Muniz; D S Howell; Z Schwartz
Journal:  Calcif Tissue Int       Date:  1996-08       Impact factor: 4.333

10.  Growth plate chondrocytes store latent transforming growth factor (TGF)-beta 1 in their matrix through latent TGF-beta 1 binding protein-1.

Authors:  H A Pedrozo; Z Schwartz; R Gomez; A Ornoy; W Xin-Sheng; S L Dallas; L F Bonewald; D D Dean; B D Boyan
Journal:  J Cell Physiol       Date:  1998-11       Impact factor: 6.384

View more
  9 in total

1.  Proteome analysis during chondrocyte differentiation in a new chondrogenesis model using human umbilical cord stroma mesenchymal stem cells.

Authors:  Alexandre De la Fuente; Jesús Mateos; Iván Lesende-Rodríguez; Valentina Calamia; Isaac Fuentes-Boquete; Francisco J de Toro; Maria C Arufe; Francisco J Blanco
Journal:  Mol Cell Proteomics       Date:  2011-10-17       Impact factor: 5.911

2.  Effects of 1,25-Dihydroxy vitamin D3 on TNF-α induced inflammation in human chondrocytes and SW1353 cells: a possible role for toll-like receptors.

Authors:  Gamze Avcioglu; Betül Özbek Ipteç; Gülben Akcan; Büsra Görgün; Kübra Fidan; Ahmet Carhan; Gulsen Yilmaz; Leyla Didem Kozaci
Journal:  Mol Cell Biochem       Date:  2019-11-16       Impact factor: 3.396

3.  Disturbances of parathyroid hormone-vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study.

Authors:  Arash Miroliaee; Mohsen Nasiri-Toosi; Omid Khalilzadeh; Alireza Esteghamati; Alireza Abdollahi; Mehdi Mazloumi
Journal:  Hepatol Int       Date:  2010-07-25       Impact factor: 6.047

4.  Effects of pulsed electromagnetic fields on human osteoblastlike cells (MG-63): a pilot study.

Authors:  Vincenzo Sollazzo; Annalisa Palmieri; Furio Pezzetti; Leo Massari; Francesco Carinci
Journal:  Clin Orthop Relat Res       Date:  2010-04-13       Impact factor: 4.176

Review 5.  Role of matrix vesicles in biomineralization.

Authors:  Ellis E Golub
Journal:  Biochim Biophys Acta       Date:  2009-09-26

6.  Role of vitamin D3 in treatment of lumbar disc herniation--pain and sensory aspects: study protocol for a randomized controlled trial.

Authors:  Mahsa Sedighi; Ali Haghnegahdar
Journal:  Trials       Date:  2014-09-25       Impact factor: 2.279

Review 7.  Nutritionally-induced catch-up growth.

Authors:  Galia Gat-Yablonski; Moshe Phillip
Journal:  Nutrients       Date:  2015-01-14       Impact factor: 5.717

8.  Vitamin D Receptor Gene Polymorphisms and Risk of Knee Osteoarthritis: Possible Correlations with TNF-α, Macrophage Migration Inhibitory Factor, and 25-Hydroxycholecalciferol Status.

Authors:  Mohammed H Hassan; Amer Alkot Mostafa Elsadek; Marwa Ahmed Mahmoud; Bakheet E M Elsadek
Journal:  Biochem Genet       Date:  2021-08-09       Impact factor: 1.890

Review 9.  Undernutrition in patients with COPD and its treatment.

Authors:  Masayuki Itoh; Takao Tsuji; Kenji Nemoto; Hiroyuki Nakamura; Kazutetsu Aoshiba
Journal:  Nutrients       Date:  2013-04-18       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.